Adam Finn

University of Bristol - Bristol Vaccine Centre

SCHOLARLY PAPERS

12

DOWNLOADS
Rank 279

SSRN RANKINGS

Top 279

in Total Papers Downloads

95,237

SSRN CITATIONS

5

CROSSREF CITATIONS

2

Scholarly Papers (12)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Federal University of São Paulo (UNIFESP), University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand, Stellenbosch University - Family Centre for Research with Ubuntu, Soweto Clinical Trials Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, GSK plc, University of Oxford - The Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, University of Liverpool - School of Tropical Medicine, University of Bristol - Bristol Vaccine Centre, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Hospital Universitário de Santa Maria, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, University of Cambridge - Department of Medicine, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group and Independent
Downloads 52,313 (48)
Citation 3

Abstract:

Loading...

2.

Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine

Number of pages: 45 Posted: 25 Jun 2021
University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Public Health England Colindale, Government of the United Kingdom - Public Health Scotland, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Liverpool - School of Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University Hospitals Birmingham NHS Foundation Trust, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, Government of the United Kingdom - North Bristol NHS Trust, NIHR UCLH Clinical Research Facility, Public Health England - Immunisation, Hepatitis, and Blood Safety Department, University of Southampton - University Hospital Southampton NHS Foundation Trust, Nottingham University Hospitals NHS Trust, Imperial College London - National Heart & Lung Institute, University of Nottingham - Division of Epidemiology and Public Health, University of Oxford - Centre for Vaccinology and Tropical Medicine and Independent
Downloads 25,259 (189)
Citation 6

Abstract:

Loading...

3.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge - Department of Medicine, University of Oxford - Big Data Institute, University of Oxford - The Jenner Institute, Public Health England - National Infection Service, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, GSK plc, University of Oxford - The Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Liverpool - School of Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Bristol - Bristol Vaccine Centre, University of Oxford - The Jenner Institute, University of Oxford - Jenner Institute, St George’s University London - St George’s Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, Genomics England, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Imperial College London - Department of Infectious Disease, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Chinese Academy of Medical Science Oxford Institute (COI), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Independent and Independent
Downloads 10,871 (873)
Citation 26

Abstract:

Loading...

4.

The Safety and Immunogenicity of Concomitant Administration of COVID-19 Vaccines (ChAdOx1 or BNT162b2) with Seasonal Influenza Vaccines in Adults: A Phase IV, Multicentre Randomised Controlled Trial with Blinding (ComFluCOV)

Number of pages: 36 Posted: 30 Sep 2021
University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University of Bristol, University Hospitals Bristol, Cardiff University - Centre for Trials Research, University of Bristol - Bristol Vaccine Centre, University Hospitals Bristol, Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Royal United Hospitals Bath NHS Foundation Trust, Public Health England - National Infection Service, University of Bristol, University of Bristol, University of Bristol, University of Bristol, National Health Service, United Kingdom, NIHR UCLH Clinical Research Facility, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, University Hospitals Bristol - University Hospitals Bristol NHS Foundation Trust, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - Great Western Hospitals, The Alverton Practice, University of Bristol, University of Bristol, University of Oxford - Centre for Vaccinology and Tropical Medicine, Government of the United Kingdom - National Health Service (NHS), Government of the United Kingdom - National Health Service (NHS), University of Nottingham - Division of Epidemiology and Public Health, University of Bristol - Bristol Vaccine Centre, University of Bristol and Independent
Downloads 3,339 (6,499)

Abstract:

Loading...

Concomitant vaccination, COVID-19 vaccine, Influenza vaccine, Clinical Trial

5.

Assessing the Effectiveness of BNT162b2 and ChAdOx1nCoV-19 COVID-19 Vaccination in Prevention of Hospitalisations in Elderly and Frail Adults: A Single Centre Test Negative Case-Control Study

Number of pages: 32 Posted: 03 Mar 2021
University of Bristol - Population Health Sciences, University of Bristol - Population Health Sciences, Southmead Hospital - Academic Respiratory Unit, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, Southmead Hospital - North Bristol NHS Trust, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, Southmead Hospital - North Bristol NHS Trust, Southmead Hospital - North Bristol NHS Trust, Southmead Hospital - North Bristol NHS Trust, University of Bristol - Population Health Sciences, University of Bristol - Population Health Sciences, University of Bristol - Population Health Sciences, University of Bristol - Population Health Sciences, University of Bristol - Population Health Sciences, University of Bristol - Engineering Mathematics and University of Bristol - Bristol Vaccine Centre
Downloads 2,883 (8,166)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, respiratory infection, vaccination

6.

Pivotal Immune-Bridging Study of the Inactivated Whole-Virus COVID-19 Vaccine VLA2001: A Phase 3, Randomized Controlled Clinical Trial in Adults Using Adenoviral Vector Vaccine AZD1222 as a Comparator

Number of pages: 33 Posted: 01 Jun 2022
University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH, Valneva Austria GmbH and University of Bristol - Bristol Vaccine Centre
Downloads 197 (272,651)
Citation 1

Abstract:

Loading...

Coronavirus, SARS-CoV-2, COVID-19, whole-virus vaccine, inactivated vaccine, adjuvanted vaccine, neutralizing antibody, vaccine safety, S protein binding IgG antibody, RBD-binding IgG antibody, CpG 1018, aluminum hydroxide.

7.

Effectiveness of BNT162b2 COVID-19 Vaccination in Prevention of Hospitalisations and Severe Disease in Adults with Delta (B.1.617.2) and Omicron (B.1.1.529) Variant SARS-CoV-2 Infection: A Prospective Test Negative Case-Control Study

Number of pages: 39 Posted: 12 Sep 2022
University of Bristol - Department of Engineering Mathematics, University of Bristol - Population Health Sciences, University of Bristol - Department of Mathematics, University of Bristol - Population Health Sciences, University Hospitals Bristol & Weston NHS Foundation Trust - Clinical Research and Imaging Centre, University of Bristol - Population Health Sciences, University of Bristol - Department of Population Health Sciences, University of Bristol - Bristol Vaccine Centre, University of Bristol - Academic Respiratory Unit, University of Bristol - Bristol Vaccine Centre, University of Bristol - Engineering Mathematics and University of Bristol - Bristol Vaccine Centre
Downloads 114 (426,069)

Abstract:

Loading...

COVID-19, SARS-CoV-2, respiratory infection, vaccination

8.

Incidence of Community Acquired Lower Respiratory Tract Disease in Bristol, UK During the COVID-19 Pandemic

Number of pages: 31 Posted: 19 Apr 2022
University of Bristol - Population Health Sciences, University of Bristol - Department of Mathematics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, University of Bristol - Academic Respiratory Unit, University of Bristol - Department of Population Health Sciences, University of Bristol - Population Health Sciences, University of Bristol - Department of Population Health Sciences, Pfizer, Inc., Pfizer, Inc., University of Bristol - Bristol Vaccine Centre, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., University of Bristol - Department of Population Health Sciences, University of Bristol - Academic Respiratory Unit, Pfizer Inc. - Medical and Scientific Affairs, University of Bristol - Engineering Mathematics and University of Bristol - Bristol Vaccine Centre
Downloads 106 (449,218)
Citation 3

Abstract:

Loading...

pneumonia, lower respiratory tract infection, cardiac failure, COVID-19, SARS-CoV-2

9.

Prospective Study of Loss of Health-Related Quality Adjusted Life Years in Children and Their Families Due to Uncomplicated and Hospitalised Varicella

Number of pages: 21 Posted: 24 Oct 2022
Universidade de Coimbra - Centro Hospitalar, University of Bristol - Population Health Sciences, Centro Hospitalar Universitário de Lisboa Central, Hospital Dr. Fernando da Fonseca, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Universidade de Coimbra - Centro Hospitalar, Hospital Infante D. Pedro, Centro Hospitalar Vila Nova de Gaia/Espinho, Hospital de Braga, Centro Hospitalar Universitário Lisboa Norte (CHLN), Hospital Beatriz Ângelo, Instituto Federal do Espírito Santo, Centro Materno Infantil do Norte, Hospital Nélio Mendonça, Centro Hospitalar Universitário de São João, Centro Hospitalar e Universitário do Algarve, Centro Hospitalar Leiria Pomba, Hospital do Divino Espírito Santo, University of Bristol - Bristol Vaccine Centre and University of Bristol - Bristol Vaccine Centre
Downloads 63 (612,903)

Abstract:

Loading...

Varicella, Health Related Quality of Life (HRQoL), Quality Adjusted Life Years (QALYs), Vaccine, Cost-effectiveness

10.

Impact of SARS-CoV-2 Infective Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) on Clinical Outcomes in a Prospective Cohort Study of Hospitalised Adults

Number of pages: 36 Posted: 21 Oct 2022
University of Bristol - Population Health Sciences, University of Bristol - Academic Respiratory Unit, University of Bristol - Academic Respiratory Unit, University of Bristol - Department of Mathematics, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, University of Bristol - Academic Respiratory Unit, University of Bristol - Bristol Vaccine Centre, University of Bristol - Academic Respiratory Unit, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, University of Bristol - Bristol Vaccine Centre, University of Bristol - Department of Population Health Sciences, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer Inc. - Medical and Scientific Affairs, University of Bristol - Bristol Vaccine Centre, University of Bristol - Engineering Mathematics, University of Bristol - Academic Respiratory Unit and Independent
Downloads 35 (783,475)

Abstract:

Loading...

COVID-19, SARS-CoV-2, acute exacerbation of COPD, COPD, airways disease, respiratory infection

11.

Maternal Vaccination Provision in NHS Maternity Trusts Across England

Number of pages: 13 Posted: 24 Aug 2023
University of Bristol, University of Bristol, University of Bristol - Bristol Vaccine Centre, University of Bristol, UK Health Security Agency and University of Bristol
Downloads 34 (791,044)

Abstract:

Loading...

Vaccination coverage, Pregnant women, Hospitals, maternity, Immunisation Programmes, England, Pertussis vaccine

12.

Parapneumonic Effusions Related to Streptococcus Pneumoniae: Serotype and Disease Severity Trends

Number of pages: 31 Posted: 27 Jun 2022
University of Bristol - Population Health Sciences, University of Bristol - Academic Respiratory Unit, University Hospitals Bristol NHS Foundation Trust - Clinical Research and Imaging Centre, Public Health England - Immunisation and Countermeasures Division, Government of the United Kingdom - Microbiology Services, Southmead Hospital - North Bristol NHS Trust, Government of the United Kingdom - Microbiology Services, Government of the United Kingdom - North Bristol NHS Trust, UK Health Security Agency, Government of the United Kingdom - Microbiology Services, University of Bristol - Engineering Mathematics, Government of the United Kingdom - Microbiology Services, Public Health England - Immunisation and Countermeasures Division, University of Bristol - Bristol Vaccine Centre and University of Bristol - Academic Respiratory Unit
Downloads 23 (882,980)

Abstract:

Loading...

pleural disease, pleural infection, pneumococcus, Streptococcus pneumoniae, serotypes, vaccination, conjugate vaccines